autologous cell-free alpha-2-macroglobulin therapy (Cytonics)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameautologous cell-free alpha-2-macroglobulin therapy (Cytonics)
Drug Alias NameA2M therapy (Cytonics)
ClassificationBiologics
Mechanisms of ActionMatrix metalloproteinase inhibitorsADAMTS5 inhibitors
TargetsMatrix metalloproteinaseADAMTS5
Therapy Area/IndicationsMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytonics Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytonics Co
Active IndicationsN/A
Inactive IndicationsMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A